Biotech News
Vaccinex Reports Third Quarter 2024 Financial Results and Provides Corporate Update
ir.vaccinex.com2026-05-06 15:18 EST
Actively Exploring Partnership for Alzheimer’s Development Supplementary Financing Concluded in Q4 ROCHESTER, N.Y. , Nov. 18, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease and